Javier
Arbizu Lostao
Consultor Médico
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
Madrid, EspañaCentro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas-ko ikertzaileekin lankidetzan egindako argitalpenak (8)
2019
-
Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: A cross-sectional analysis from the AB255 Study
Alzheimer's Research and Therapy, Vol. 11, Núm. 1
2014
-
Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: A two-step process
Brain, Vol. 137, Núm. 8, pp. 2356-2367
2012
-
Decreased carbon-11-flumazenil binding in early Alzheimer's disease
Brain, Vol. 135, Núm. 9, pp. 2817-2825
-
Usefulness of positron emission tomography with fludeoxyglucose F 18 and with carbon 11-tagged methionine in the diagnosis of hippocampal lesions
Archives of Neurology, Vol. 69, Núm. 12, pp. 1652-1653
2010
-
Brain glucose metabolism in vascular white matter disease with dementia: Differentiation from Alzheimer disease
Stroke, Vol. 41, Núm. 12, pp. 2889-2893
-
Neuroimagen: Fundamentos técnicos y prácticos
Revista Espanola de Medicina Nuclear, Vol. 29, Núm. 4, pp. 189-210
2009
-
New MRI, 18F-DOPA and 11C-(+)-α-dihydrotetrabenazine templates for Macaca fascicularis neuroimaging: Advantages to improve PET quantification
NeuroImage, Vol. 47, Núm. 2, pp. 533-539
2008
-
Successful thalamic deep brain stimulation for orthostatic tremor
Movement Disorders, Vol. 23, Núm. 13, pp. 1808-1811